Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
The guidelines took years to finalize, but while regulators were drafting them, a new trend emerged: online pharmaceutical ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...
Investor's Business Daily on MSN3d
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
Woman's World on MSN3d
Does Phenylephrine Work? Effective Alternatives as FDA Moves to Ban Ingredient in OTC DecongestantsCommon decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...
ALK will initially focus on bringing neffy® to the markets in Europe and Canada, the world's second and third largest adrenaline autoinjector ("AAI”) markets. In both markets, the product can be added ...
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback